BIOVECTRA Company Overview

BioVectra offers contract development and manufacturing capacity for intermediates and active pharmaceutical ingredients (APIs) from five North American cGMP facilities. We specialize in Microbial Fermentation, Complex Chemistry, Biologics, and Formulation Development.

This case study presents the successful collaboration between an early-stage company that was struggling with the development of a realistic and economically viable commercial pathway and BioVectra, a CDMO with 50 years of experience.

This Whitepaper outlines what a platform technology is and how it can speed up process development, the impact of high-throughput technologies, and what single-use, disposable technologies are currently on the market for biologics manufacturing.

The production of increasingly complex small molecule APIs is challenging. CDMOs with multiple capabilities are needed to develop efficient routes to synthesize these complicated molecules. This paper outlines how BioVectra supports client projects.